| Dr Christina Michelle Mendez Land, AUD | |
|
7509 Menchaca Rd Unit 302, Austin, TX 78745-6061 | |
| (512) 829-8690 | |
| (512) 661-2056 |
| Full Name | Dr Christina Michelle Mendez Land |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 9 Years |
| Location | 7509 Menchaca Rd Unit 302, Austin, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316499247 | NPI | - | NPPES |
| 80796 | Other | TX | TDLR - STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 80796 (Texas) | Primary |
| Provider Name | Land Audiology Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1659841203 PECOS PAC ID: 3476893173 Enrollment ID: O20190315001007 |
News Archive
What about in vitro fertilization, a process that both creates and discards embryos? What new rights would be afforded to a fetus, and how would those rights affect or compete with the rights of the woman who carries it? Would a woman who has an abortion be guilty of murder and subject to capital punishment? ... In their quest to ban abortion in Mississippi, the amendment's drafters appear to have rushed past such concerns.
A multi-institute study led by Monash University has revealed for the first time the mechanism that regulates fluid intake in the human body and stops us from over-drinking, which can cause potentially fatal water intoxication.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has successfully completed a Phase 1B/2 dose-ranging clinical study with PMX-60056, a synthetic small-molecule designed to reverse heparin and low molecular weight heparin anticoagulants.
Researchers from the University of Surrey have today launched a new programme of research called eSMART (Electronic Symptom Management using ASyMS Remote Technology), that uses mobile phone technology to remotely monitor patients who are undergoing chemotherapy to treat breast, bowel and blood cancers.
PharmaEngine, Inc. and Merrimack Pharmaceuticals, Inc. announced today the execution of an agreement under which PharmaEngine grants back to Merrimack the rights to develop, manufacture, and commercialize PEP02 in Asia and Europe, with the exception of Taiwan.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christina Michelle Mendez Land, AUD 7509 Menchaca Rd Unit 302, Austin, TX 78745-6061 Ph: (512) 829-8690 | Dr Christina Michelle Mendez Land, AUD 7509 Menchaca Rd Unit 302, Austin, TX 78745-6061 Ph: (512) 829-8690 |
News Archive
What about in vitro fertilization, a process that both creates and discards embryos? What new rights would be afforded to a fetus, and how would those rights affect or compete with the rights of the woman who carries it? Would a woman who has an abortion be guilty of murder and subject to capital punishment? ... In their quest to ban abortion in Mississippi, the amendment's drafters appear to have rushed past such concerns.
A multi-institute study led by Monash University has revealed for the first time the mechanism that regulates fluid intake in the human body and stops us from over-drinking, which can cause potentially fatal water intoxication.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has successfully completed a Phase 1B/2 dose-ranging clinical study with PMX-60056, a synthetic small-molecule designed to reverse heparin and low molecular weight heparin anticoagulants.
Researchers from the University of Surrey have today launched a new programme of research called eSMART (Electronic Symptom Management using ASyMS Remote Technology), that uses mobile phone technology to remotely monitor patients who are undergoing chemotherapy to treat breast, bowel and blood cancers.
PharmaEngine, Inc. and Merrimack Pharmaceuticals, Inc. announced today the execution of an agreement under which PharmaEngine grants back to Merrimack the rights to develop, manufacture, and commercialize PEP02 in Asia and Europe, with the exception of Taiwan.
› Verified 7 days ago
Dr. William Blunk, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 3816 S 1st St, Austin, TX 78704 Phone: 512-443-1311 Fax: 512-406-6266 | |
Bhavana Kancherla, M.A., CCC/A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1208 Tamranae Ct, Austin, TX 78746 Phone: 412-855-9296 | |
Carmen Tyler, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 211 Comal St, Austin, TX 78702 Phone: 512-978-9200 Fax: 512-978-9238 | |
Maribeth Collins, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 3705 Medical Pkwy Ste 200, Austin, TX 78705 Phone: 512-324-2720 | |
Dr. Bart Edward Noble, PH.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2901 S. Montopolis Dr., Austin, TX 78741 Phone: 512-389-6505 Fax: 512-389-6559 | |
Rachel C Spinuzza, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 3607 Manor Rd Ste 101, Austin, TX 78723 Phone: 512-478-2273 Fax: 512-472-0921 | |
Connect Hearing, Inc. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3201 Bee Caves Rd Ste 146, Austin, TX 78746 Phone: 512-327-8845 Fax: 512-327-8843 |